These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 38433454)
1. Retrospective evaluation of leflunomide as an adjunctive therapy in dogs with non-associative immune-mediated thrombocytopenia: 20 cases (2008-2021). Spear DJ; Crouse ZJ; Kearns SA J Small Anim Pract; 2024 Apr; 65(4):261-269. PubMed ID: 38433454 [TBL] [Abstract][Full Text] [Related]
2. Long-term outcome of primary immune-mediated thrombocytopenia in dogs. Simpson K; Chapman P; Klag A J Small Anim Pract; 2018 Nov; 59(11):674-680. PubMed ID: 30102418 [TBL] [Abstract][Full Text] [Related]
3. Treatment of presumptive primary immune-mediated thrombocytopenia with mycophenolate mofetil versus cyclosporine in dogs. Cummings FO; Rizzo SA J Small Anim Pract; 2017 Feb; 58(2):96-102. PubMed ID: 28160307 [TBL] [Abstract][Full Text] [Related]
4. Treatment of severe immune-mediated thrombocytopenia with human IV immunoglobulin in 5 dogs. Bianco D; Armstrong PJ; Washabau RJ J Vet Intern Med; 2007; 21(4):694-9. PubMed ID: 17708388 [TBL] [Abstract][Full Text] [Related]
5. Leflunomide with prednisone or nonsteroidal anti-inflammatory drug therapy is safe and tolerated for long-term treatment of immune-mediated polyarthritis in 27 dogs. Chesne RB; Doornink MT; Sri-Jayantha LSH; Urie BK J Am Vet Med Assoc; 2024 Sep; 262(9):1188-1192. PubMed ID: 38608652 [TBL] [Abstract][Full Text] [Related]
6. Use of human intravenous immunoglobulin for the treatment of 12 dogs with newly diagnosed malignant disease and presumed secondary immune-mediated thrombocytopenia. Stikeman E; Bianco D J Small Anim Pract; 2024 May; 65(5):338-345. PubMed ID: 38239177 [TBL] [Abstract][Full Text] [Related]
7. A Retrospective Study on the Safety and Efficacy of Leflunomide in Dogs. Sato M; Veir JK; Legare M; Lappin MR J Vet Intern Med; 2017 Sep; 31(5):1502-1507. PubMed ID: 28833582 [TBL] [Abstract][Full Text] [Related]
8. Immunomodulatory and immunosuppressive drug protocols in the treatment of canine primary immune thrombocytopenia, a scoping review. Kristiansen PS; Nielsen LN Acta Vet Scand; 2021 Dec; 63(1):54. PubMed ID: 34961516 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of leflunomide for treatment of refractory inflammatory colorectal polyps in 15 Miniature Dachshunds. Fukushima K; Eguchi N; Ohno K; Kanemoto H; Takahashi M; Igarashi H; Ohmi A; Nakashima K; Tsujimoto H J Vet Med Sci; 2016 Feb; 78(2):265-9. PubMed ID: 26460312 [TBL] [Abstract][Full Text] [Related]
10. Acquired amegakaryocytic thrombocytopenia--four cases and a literature review. Lachowicz JL; Post GS; Moroff SD; Mooney SC J Small Anim Pract; 2004 Oct; 45(10):507-14. PubMed ID: 15515801 [TBL] [Abstract][Full Text] [Related]
11. Primary immune-mediated thrombocytopenia in 30 dogs (1997-2003). Putsche JC; Kohn B J Am Anim Hosp Assoc; 2008; 44(5):250-7. PubMed ID: 18762561 [TBL] [Abstract][Full Text] [Related]
12. Treatment and predictors of outcome in dogs with immune-mediated thrombocytopenia. O'Marra SK; Delaforcade AM; Shaw SP J Am Vet Med Assoc; 2011 Feb; 238(3):346-52. PubMed ID: 21281218 [TBL] [Abstract][Full Text] [Related]
13. Immune-mediated hemolytic anemia and severe thrombocytopenia in dogs: 12 cases (2001-2008). Orcutt ES; Lee JA; Bianco D J Vet Emerg Crit Care (San Antonio); 2010 Jun; 20(3):338-45. PubMed ID: 20636987 [TBL] [Abstract][Full Text] [Related]
14. Treatment of canine idiopathic immune-mediated haemolytic anaemia with mycophenolate mofetil and glucocorticoids: 30 cases (2007 to 2011). Wang A; Smith JR; Creevy KE J Small Anim Pract; 2013 Aug; 54(8):399-404. PubMed ID: 23879827 [TBL] [Abstract][Full Text] [Related]
15. A prospective randomized clinical trial of vincristine versus human intravenous immunoglobulin for acute adjunctive management of presumptive primary immune-mediated thrombocytopenia in dogs. Balog K; Huang AA; Sum SO; Moore GE; Thompson C; Scott-Moncrieff JC J Vet Intern Med; 2013; 27(3):536-41. PubMed ID: 23527952 [TBL] [Abstract][Full Text] [Related]
16. A prospective, randomized, double-blinded, placebo-controlled study of human intravenous immunoglobulin for the acute management of presumptive primary immune-mediated thrombocytopenia in dogs. Bianco D; Armstrong PJ; Washabau RJ J Vet Intern Med; 2009; 23(5):1071-8. PubMed ID: 19674280 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of leflunomide for treatment of immune-mediated polyarthritis in dogs: 14 cases (2006-2008). Colopy SA; Baker TA; Muir P J Am Vet Med Assoc; 2010 Feb; 236(3):312-8. PubMed ID: 20113244 [TBL] [Abstract][Full Text] [Related]
18. Presumed primary immune-mediated neutropenia in 35 dogs: a retrospective study. Devine L; Armstrong PJ; Whittemore JC; Sharkey L; Bailiff N; Huang A; Rishniw M J Small Anim Pract; 2017 Jun; 58(6):307-313. PubMed ID: 28245056 [TBL] [Abstract][Full Text] [Related]
19. Application of therapeutic plasma exchange in dogs with immune-mediated thrombocytopenia. Kopecny L; Palm CA; Naylor S; Kirby J; Cowgill LD J Vet Intern Med; 2020 Jul; 34(4):1576-1581. PubMed ID: 32557826 [TBL] [Abstract][Full Text] [Related]
20. Treatment of Evans' syndrome with human intravenous immunoglobulin and leflunomide in a diabetic dog. Bianco D; Hardy RM J Am Anim Hosp Assoc; 2009; 45(3):147-50. PubMed ID: 19411652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]